Acral Necrosis After PD-L1 Immune Checkpoint Inhibitor Therapy

Cutis. 2023 May;111(5):E16-E17. doi: 10.12788/cutis.0777.

Authors

Sam Logan¹, Michi M Shinohara¹

Affiliation

¹ Dr. Logan is from the Department of Dermatology, University of Colorado, Aurora. Dr. Shinohara is from the Department of Dermatology, University of Washington, Seattle.

PMID: 37406326
DOI: 10.12788/cutis.0777

No abstract available

Publication types

Letter

MeSH terms

B7-H1 Antigen / therapeutic use
Humans
Immune Checkpoint Inhibitors* / adverse effects
Melanoma* / drug therapy
Necrosis / chemically induced

Substances

Immune Checkpoint Inhibitors
B7-H1 Antigen